Using a cut off of 37 pg/ml of IFN-γ to define a responder status, more than 80% of patients and contacts from endemic areas responded to all the antigens except ACP3 to which only 47% of active Buruli ulcer cases and 71% of contacts responded. Here, ACP3 is linked to Buruli ulcer disease.